| Literature DB >> 29304016 |
Ronghua Wu1, Xiuzhen Sheng2, Xiaoqian Tang3, Jing Xing4, Wenbin Zhan5,6.
Abstract
Lymphocystis disease virus (LCDV) infection may induce a variety of host gene expression changes associated with disease development; however, our understanding of the molecular mechanisms underlying host-virus interactions is limited. In this study, RNA sequencing (RNA-seq) was employed to investigate differentially expressed genes (DEGs) in the gill of the flounder (Paralichthys olivaceus) at one week post LCDV infection. Transcriptome sequencing of the gill with and without LCDV infection was performed using the Illumina HiSeq 2500 platform. In total, RNA-seq analysis generated 193,225,170 clean reads aligned with 106,293 unigenes. Among them, 1812 genes were up-regulated and 1626 genes were down-regulated after LCDV infection. The DEGs related to cellular process and metabolism occupied the dominant position involved in the LCDV infection. A further function analysis demonstrated that the genes related to inflammation, the ubiquitin-proteasome pathway, cell proliferation, apoptosis, tumor formation, and anti-viral defense showed a differential expression. Several DEGs including β actin, toll-like receptors, cytokine-related genes, antiviral related genes, and apoptosis related genes were involved in LCDV entry and immune response. In addition, RNA-seq data was validated by quantitative real-time PCR. For the first time, the comprehensive gene expression study provided valuable insights into the host-pathogen interaction between flounder and LCDV.Entities:
Keywords: Paralichthys olivaceus; differentially expressed genes; lymphocystis disease virus; transcriptome sequencing
Mesh:
Substances:
Year: 2018 PMID: 29304016 PMCID: PMC5796109 DOI: 10.3390/ijms19010160
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
The detection results of RNA from Agilent 2100.
| Sample Name | OD260/OD280 | 28S/18S RNA Ratio | RIN Value |
|---|---|---|---|
| PBS-G1 | 1.853 ± 0.086 | 1.7 ± 0.3 | 8.9 ± 0.3 |
| PBS-G2 | 1.887 ± 0.104 | 1.8 ± 0.2 | 8.7 ± 0.2 |
| LCDV-G1 | 1.971 ± 0.018 | 2.1 ± 0.1 | 9.1 ± 0.1 |
| LCDV-G2 | 1.865 ± 0.117 | 1.9 ± 0.2 | 9.3 ± 0.2 |
PBS, phosphate buffer solution; LCDV, lymphocystis disease virus; RIN, RNA integrity number.
Summary of sequences analysis.
| Category | PBS-G1 | PBS-G2 | LCDV-G1 | LCDV-G2 | Summary |
|---|---|---|---|---|---|
| Raw reads | 47,382,188 | 41,257,434 | 55,497,824 | 59,422,436 | 203,559,882 |
| Clean reads | 46,280,260 | 40,363,354 | 51,413,710 | 55,167,846 | 193,225,170 |
| Q20 (%) | 93.12–95.21 | 93.13–95.29 | 92.05–96.24 | 91.72–96.35 | |
| GC (%) | 47.69–47.71 | 47.51–47.53 | 47.41–47.55 | 47.61–47.76 | |
| Total mapped | 39,092,630 (84.47%) | 34,395,222 (85.21%) | 43,059,442 (83.75%) | 46,511,408 (84.31%) |
Q20: The percentage of bases with a Phred value >20.
Figure 1Length distribution of assembled unigenes. X-axis, unigene length; Y-axis, length frequency.
BLAST analysis of non-redundant unigenes against seven different databases.
| Annotation in Database | Number of Unigenes | Percentage (%) |
|---|---|---|
| Annotated in Nr | 24,922 | 23.44 |
| Annotated in Nt | 27,528 | 25.89 |
| Annotated in | 12,881 | 12.11 |
| Annotated in Swiss-Prot | 21,572 | 20.29 |
| Annotated in Pfam | 23,245 | 21.86 |
| Annotated in GO | 24,187 | 22.75 |
| Annotated in KOG | 13,871 | 13.04 |
| Annotated in all databases | 8207 | 7.72 |
| Annotated in at least one database | 36,537 | 34.37 |
| Total unigenes | 106,293 | 100 |
Figure 2GO classification of assembled unigenes. X-axis, three major functional categories of GO terms: biological process, cellular component, and molecular function; Y-axis, terms with numbers/percents of unigenes in the major category.
Figure 3KOG classification of assembled unigenes. X-axis, the name of 26 groups in KOG; Y-axis, percentage of gene annotated in the group.
Figure 4KEGG classification of the 23,468 unigenes. Five capital letters with the corresponding colored bars indicate five main categories. A: cellular processes; B: environmental information processing; C: genetic information processing; D: metabolism; E: organism systems.
Figure 5The ‘‘volcano plot’’ picture of DEGs between LCDV-infected and control groups. Red spots and green spots represented significantly up-regulated and down-regulated genes, respectively (padj < 0.05 and |log2 (fold change)| > 1). Blue spots: no difference in gene expression.
Figure 6Enriched GO Terms of DEGs. X-axis, three main categories: biological process (BP), cellular component (CC), and molecular function (MF); Y-axis, number/percent DEGs of a term in the total annotated DEGs.
The 15 significant enrichment of pathways for differentially expressed genes (DEGs). The pathway ID was obtained from the KEGG database. Pathways with a corrected p value < 0.05 were significantly enriched.
| Pathways | Pathways ID | Branch in the KEGG Database | Up-/Down-Regulated Genes |
|---|---|---|---|
| Proteasome | ko03050 | genetic information processing | 25/0 |
| Base excision repair | ko03410 | genetic information processing | 9/1 |
| Homologous recombination | ko03440 | genetic information processing | 7/2 |
| DNA replication | ko03030 | genetic information processing | 12/0 |
| Mismatch repair | ko03430 | genetic information processing | 7/0 |
| Spliceosome | ko03040 | genetic information processing | 22/3 |
| Aminoacyl-tRNA biosynthesis | ko00970 | genetic information processing | 10/0 |
| Nucleotide excision repair | ko03420 | genetic information processing | 10/0 |
| Metabolic pathways | ko01100 | metabolism | 128/77 |
| Glutathione metabolism | ko00480 | metabolism | 11/3 |
| Other types of | ko00514 | metabolism | 6/4 |
| Amino sugar and nucleotide sugar metabolism | ko00520 | metabolism | 9/7 |
| p53 signaling pathway | ko04115 | cellular processes | 15/8 |
| Cell cycle | ko04110 | cellular processes | 27/8 |
| Tumor necrosis factor (TNF) signaling pathway | ko04668 | environmental information processing | 16/9 |
Expression of virus-entry and immune-related DEGs in gill tissues at one week post LCDV infection.
| Gene Name | Expression after Infection | Expression in Control | Ratio of Expression (Infection vs. Control) |
|---|---|---|---|
| 12,056 | 7655 | 1.575 | |
| 38 | 4 | 9.500 | |
| 409 | 1259 | 0.325 | |
| 286 | 138 | 2.072 | |
| 15,252 | 9252 | 1.649 | |
| 5521 | 3731 | 1.480 | |
| 145 | 68 | 2.132 | |
| 355 | 223 | 1.592 | |
| 217 | 49 | 4.429 | |
| 564 | 315 | 1.790 | |
| 413 | 242 | 1.707 | |
| 589 | 216 | 2.727 | |
| 124 | 24 | 5.167 | |
| 218 | 85 | 2.565 | |
| 4244 | 2835 | 1.497 | |
| 1009 | 634 | 1.591 | |
| 284 | 158 | 1.797 | |
| 1393 | 979 | 1.423 | |
| 787 | 537 | 1.466 | |
| 166 | 90 | 1.844 | |
| 111 | 361 | 0.307 | |
| 26 | 115 | 0.226 | |
| 82 | 207 | 0.396 | |
| 883 | 405 | 2.180 | |
| 553 | 305 | 1.813 | |
| 4776 | 2516 | 1.898 | |
| 666 | 452 | 1.473 | |
| 1186 | 3661 | 0.324 | |
| 883 | 405 | 2.180 | |
| 553 | 305 | 1.813 | |
| 666 | 452 | 1.473 | |
| 21 | 129 | 0.163 | |
| 2053 | 1136 | 1.807 | |
| 1209 | 628 | 1.925 | |
| 402 | 641 | 0.627 | |
| 3392 | 1213 | 2.796 | |
| 47,080 | 19,068 | 2.469 | |
| 202 | 123 | 1.642 | |
| 2199 | 3851 | 0.571 | |
| 932 | 2203 | 0.423 | |
| 1361 | 372 | 3.659 | |
| 16,310 | 8844 | 1.844 | |
| 123 | 61 | 2.016 | |
| 197 | 57 | 3.456 | |
| 352 | 221 | 1.593 | |
| 340 | 142 | 2.394 | |
| 2191 | 1409 | 1.555 | |
| 1023 | 701 | 1.459 |
Figure 7Validation of RNA-seq data by qRT-PCR. Y-axis, the relative expression level was expressed as log2 (fold change) in gene expression; X-axis, gene name. The relative expression of 10 genes, were detected by RT-qPCR (blue column) and compared with the results of RNA-seq (white column). Error bars represented standard deviation (SD).